Global Strategic Investment Solutions, LLC Bristol Myers Squibb CO Transaction History

Global Strategic Investment Solutions, LLC

$813 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $287,510 - $335,169	-5,361 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $59,584 - $69,795	1,007 Added 23.13%	5,361 $317,000
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $433 - $471	7 Added 0.16%	4,354 $291,000
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $257,950 - $290,118	4,347 New	4,347 $274,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Strategic Investment Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Strategic Investment Solutions, LLC with notifications on news.

Account